Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$871M |
| 3 |
Uber
UBER
|
+$867M |
| 4 |
NVIDIA
NVDA
|
+$687M |
| 5 |
Amazon
AMZN
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$540M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.83% |
| 2 | Financials | 12.77% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
3301
DELISTED
Ambrx Biopharma Inc
AMAM
| $1.16M | ﹤0.01% |
81,157
+31,017
| +62% | +$352K |
|
3302
Nektar Therapeutics
NKTR
$2.38B
| $1.15M | ﹤0.01% |
135,974
+5,617
| +4% | +$42.5K |
|
|
LNAI
3303
Lunai Bioworks
LNAI
$10.8M
| $1.15M | ﹤0.01% |
4,530
+741
| +20% | +$203K |
|
3304
OPAL Fuels
OPAL
$70.1M
| $1.15M | ﹤0.01% |
207,776
+22,242
| +12% | +$137K |
|
3305
Rigetti Computing
RGTI
$5.33B
| $1.15M | ﹤0.01% |
1,162,612
+94,512
| +9% | +$108K |
|
3306
Trevi Therapeutics
TRVI
$2.54B
| $1.14M | ﹤0.01% |
849,881
+62,241
| +8% | +$94.2K |
|
3307
Cellebrite
CLBT
$3.76B
| $1.14M | ﹤0.01% |
131,498
+480
| +0.4% | +$3.73K |
|
|
ARC
3308
DELISTED
ARC Document Solutions, Inc.
ARC
| $1.13M | ﹤0.01% |
345,136
+17,481
| +5% | +$51.3K |
|
|
CBIO
3309
Crescent Biopharma
CBIO
$552M
| $1.13M | ﹤0.01% |
4,789
+191
| +4% | +$29.7K |
|
3310
1stdibs.com
DIBS
$149M
| $1.13M | ﹤0.01% |
240,560
+28,350
| +13% | +$120K |
|
|
VXRT
3311
DELISTED
Vaxart
VXRT
| $1.12M | ﹤0.01% |
1,962,033
+175,398
| +10% | +$121K |
|
|
TIXT
3312
DELISTED
TELUS International
TIXT
| $1.12M | ﹤0.01% |
108,503
+11,379
| +12% | +$82.8K |
|
|
UHG
3313
DELISTED
United Homes Group
UHG
| $1.12M | ﹤0.01% |
132,919
-3,418
| -3% | -$23.8K |
|
3314
Crawford & Co Class B
CRD.B
$506M
| $1.12M | ﹤0.01% |
85,415
+3,022
| +4% | +$28.8K |
|
3315
Eldorado Gold
EGO
$8.37B
| $1.12M | ﹤0.01% |
85,966
-1,532
| -2% | -$17.2K |
|
|
LL
3316
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.12M | ﹤0.01% |
286,091
+2,695
| +1% | +$8.99K |
|
3317
Priority Technology Holdings
PRTH
$549M
| $1.12M | ﹤0.01% |
313,274
| – | – |
|
3318
LiveOne
LVO
$60.9M
| $1.11M | ﹤0.01% |
79,895
+2,954
| +4% | +$31.3K |
|
3319
System1
SST
$14.5M
| $1.11M | ﹤0.01% |
49,989
+767
| +2% | +$11.3K |
|
3320
Veritone
VERI
$103M
| $1.11M | ﹤0.01% |
613,056
+14,705
| +2% | +$32.8K |
|
3321
Atara Biotherapeutics
ATRA
$77M
| $1.1M | ﹤0.01% |
86,006
+2,943
| +4% | +$68.6K |
|
3322
American Outdoor Brands
AOUT
$161M
| $1.1M | ﹤0.01% |
131,191
+5,316
| +4% | +$45.7K |
|
3323
Abeona Therapeutics
ABEO
$364M
| $1.1M | ﹤0.01% |
219,385
+22,646
| +12% | +$99.6K |
|
3324
Nuvectis Pharma
NVCT
$681M
| $1.1M | ﹤0.01% |
131,657
+1,994
| +2% | +$17.8K |
|
3325
Baytex Energy
BTE
$3.1B
| $1.09M | ﹤0.01% |
331,070
+72,784
| +28% | +$282K |
|
Similar funds
Geode Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Geode Capital Management held 4,831 positions worth $956B, up 14% from $840B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q4 2023 filing shows 71 new, 3,576 increased, 304 reduced and 178 closed positions. Its largest new stake was NCR Atleos: 993,462 shares worth $24.2M. The largest sale was Activision Blizzard, an estimated $1.52B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2023 buy was NCR Atleos: 993,462 shares worth $24.2M.
- Geode Capital Management added most to Microsoft in Q4 2023, an estimated $1.09B increase.
- Geode Capital Management's biggest Q4 2023 reduction was Danaher, cutting an estimated $540M.
- Geode Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.52B.
- Geode Capital Management's ten largest holdings make up 26% of its $956B portfolio in Q4 2023.
- Geode Capital Management opened 71 new positions and closed 178 in Q4 2023.
- Geode Capital Management's portfolio value rose 14% quarter-over-quarter to $956B.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.